Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human IKBKB Antibodies:
anti-Rat (Rattus) IKBKB Antibodies:
anti-Mouse (Murine) IKBKB Antibodies:
Go to our pre-filtered search.
Human Monoclonal IKBKB Primary Antibody for CyTOF, FACS - ABIN252473
Verma, Stevenson, Schwarz, Van Antwerp, Miyamoto: Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. in Genes & development 1995
Show all 59 Pubmed References
Human Monoclonal IKBKB Primary Antibody for FACS - ABIN4324267
Manna, Mukhopadhyay, Aggarwal: Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis. in Journal of immunology (Baltimore, Md. : 1950) 2000
Show all 37 Pubmed References
Human Monoclonal IKBKB Primary Antibody for IP, WB - ABIN967355
DiDonato, Hayakawa, Rothwarf, Zandi, Karin: A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. in Nature 1997
Show all 12 Pubmed References
Human Monoclonal IKBKB Primary Antibody for FACS, GS - ABIN252477
Vacca, Felli, Palermo, Di Mario, Calce, Di Giovine, Frati, Gulino, Screpanti: Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia. in The EMBO journal 2006
Show all 9 Pubmed References
Human Polyclonal IKBKB Primary Antibody for IF, IHC (p) - ABIN1882097
Tang, Inohara, Wang, Nuñez, Guan: Roles for homotypic interactions and transautophosphorylation in IkappaB kinase beta IKKbeta) activation [corrected]. in The Journal of biological chemistry 2003
Show all 8 Pubmed References
Human Monoclonal IKBKB Primary Antibody for WB - ABIN1882049
Edwards: Anticipation of disaster. in Journal of the Royal Society of Medicine 1991
Show all 7 Pubmed References
Human Monoclonal IKBKB Primary Antibody for WB - ABIN387826
Niida, Tanaka, Kamitani: Downregulation of active IKK beta by Ro52-mediated autophagy. in Molecular immunology 2010
Show all 11 Pubmed References
Human Polyclonal IKBKB Primary Antibody for IHC - ABIN966373
Mercurio, Zhu, Murray, Shevchenko, Bennett, Li, Young, Barbosa, Mann, Manning, Rao: IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. in Science (New York, N.Y.) 1997
Show all 11 Pubmed References
Human Polyclonal IKBKB Primary Antibody for IHC - ABIN966375
Hu, Wang: IkappaB kinase-alpha and -beta genes are coexpressed in adult and embryonic tissues but localized to different human chromosomes. in Gene 1999
Show all 11 Pubmed References
Human Polyclonal IKBKB Primary Antibody for IHC - ABIN966374
Shindo, Nakano, Sakon, Yagita, Mihara, Okumura: Assignment of IkappaB kinase beta (IKBKB) to human chromosome band 8p12-->p11 by in situ hybridization. in Cytogenetics and cell genetics 1998
Show all 11 Pubmed References
crystal structure of IKKbeta in complex with an inhibitor, at a resolution of 3.6 A
These studies identify functional EREs in the IKKB promoter and identify IKKB as an ERalpha (show ESR1 Antibodies) and NSC35446.HCl-regulated gene, and they suggest that NF-kappaB (show NFKB1 Antibodies) and IKKB, which were previously linked to antiestrogen resistance, are targets for NSC35446.HCl in reversing antiestrogen resistance.
Curcumin suppressed CXCL5 (show CXCL5 Antibodies) expression by direct inhibition of IKKbeta phosphorylation, and inhibition of p38 MAPK (show MAPK14 Antibodies) via induction of negative regulator MKP-1 (show DUSP1 Antibodies).
This study demonstrated that nerve injury-induced Csf1 (show CSF1 Antibodies) upregulation was ameliorated indicating that IKK (show CHUK Antibodies)/NF-kappaBeta (show NFKB1 Antibodies)-dependent SGC (show SGCB Antibodies) activation induced Csf1 (show CSF1 Antibodies) expression in sensory neurons.
Findings uncover a novel function for IKKbeta/mHTTx1 interactions in regulating IL-34 (show IL34 Antibodies) production, and implicate a role for IL-34 (show IL34 Antibodies) in non-cell-autonomous, microglial-dependent neurodegeneration in HD.
HOTAIR operates the action of IKKalpha (show CHUK Antibodies), IKKbeta, IKKgamma (show IKBKG Antibodies) in liver cancer stem cells
These results suggested that APN (show ANPEP Antibodies) ameliorated endothelial inflammation and IR through ROS (show ROS1 Antibodies)/IKKbeta pathway.
p300 (show EP300 Antibodies)-dependent histone H3 (show HIST3H3 Antibodies) acetylation and C/EBPbeta (show CEBPB Antibodies)-regulated IKKbeta expression contribute to thrombin (show F2 Antibodies)-induced IL-8/CXCL8 (show IL8 Antibodies) expression in human lung epithelial cells.
EGFR (show EGFR Antibodies)/PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies)/IKK-beta/NF-kappaB (show NFKB1 Antibodies) signaling promotes head and neck cancer progression.
our results illustrate a new direction in nitrosourea treatment, and reveal that the combination of ROS (show ROS1 Antibodies)-inducing IKKbeta inhibitors with nitrosoureas can be potentially exploited for melanoma therapy
Smad7 (show SMAD7 Antibodies) expression in necrotizing enterocolitis macrophages interrupts TGF-beta (show TGFB1 Antibodies) signaling and promotes NF-kappaB (show NFKB1 Antibodies)-mediated inflammatory signaling in these cells through increased expression of IKK-beta
Staphylococcus aureus infection inhibits nuclear factor kappa B activation mediated by prolactin (show PRL Antibodies) in bovine mammary epithelial cells.
Elevated levels of common free fatty acids found in human serum activate IKKbeta in bovine endothelial cells leading to reduced nitric oxide, and may serve to link pathways involved in inflammation and endothelial dysfunction.
High glucose treatment also activated IKKbeta, and pretreatment with aspirin, a pharmacological inhibitor of IKKbeta, prevented both glucose-induced IKKbeta activation and the effect of high glucose to impair insulin (show INS Antibodies)-mediated NO production.
High glucose-induced IKK (show CHUK Antibodies)-Hsp-90 (show HSP90 Antibodies) interaction contributes to endothelial dysfunction.
NF-kappaB (show NFKB1 Antibodies) is the transcription factor in regulating many proinflammatory cytokine genes.
p55TNFR-IKK2-Ripk3 (show RIPK3 Antibodies) signalling orchestrates arthritogenic and death responses in synovial fibroblasts
Pulmonary inflammation due to lung-specific overexpression of IKK2ca was sufficient to increase circulating TNFalpha (show TNF Antibodies) and IL-6 (show IL6 Antibodies) levels, adipose expression of Tnfalpha (show TNF Antibodies) and Il-6 (show IL6 Antibodies) mRNA, aortic endothelial dysfunction, and systemic insulin (show INS Antibodies) resistance.
prolonged IKKbeta inhibition decimates circulating Tregs and improves Cytotoxic t lymphocytes responses when commenced after tumor vaccination, indicating that IKKbeta represents a druggable checkpoint.
Results reveal that IKKbeta activity prevents skin tumor development, and shed light on the complex nature of IKKbeta effects on cancer progression, as IKKbeta can both promote and prevent carcinogenesis depending on the cell type or molecular context.
IKK2 activation in astrocytes initiates selective non-cell-autonomous neurodegeneration
Chronic overnutrition and astrocytic IKKbeta/NF-kappaB (show NFKB1 Antibodies) upregulation similarly impaired astrocytic plasticity, leading to sustained shortening of high-order processes. In physiology, astrocytic IKKbeta/NF-kappaB (show NFKB1 Antibodies) upregulation resulted in early-onset effects, including glucose intolerance and blood pressure rise, and late-onset effects, including body weight and fat gain.
Expression of both wild-type and catalytically-inactive Y7F mutant GSTP (show GSTP1 Antibodies) significantly attenuated LPS (show TLR4 Antibodies)- or IKKbeta-induced production of GM-CSF (show CSF2 Antibodies). These studies indicate a complex role for GSTP (show GSTP1 Antibodies) in modulating NF-kappaB (show NFKB1 Antibodies), which may involve S-glutathionylation of IKK (show CHUK Antibodies) proteins, and interaction with NF-kappaB (show NFKB1 Antibodies) family members.
Myeloid ikkbeta gene deletion significantly reduced the percentage of CD4 (show CD4 Antibodies)(+)/IFN-gamma (show IFNG Antibodies)(+) (Th1 (show HAND1 Antibodies)) and CD4 (show CD4 Antibodies)(+)/IL-17 (show IL17A Antibodies)(+) (Th17) cells
Pharmacological and genetic inhibition of IKKbeta decreased voluntary ethanol consumption, providing initial support for IKKbeta as a potential therapeutic target for alcohol abuse.
The protein encoded by this gene phosphorylates the inhibitor in the inhibitor/NF-kappa-B complex, causing dissociation of the inhibitor and activation of NF-kappa-B. The encoded protein itself is found in a complex of proteins. Several transcript variants, some protein-coding and some not, have been found for this gene.
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
, inhibitor of nuclear factor kappa-B kinase subunit beta
, inhibitor of nuclear factor kappa-B kinase subunit beta-like
, IKK-like protein
, LPS-responsive kinase
, cactus kinase
, deficient 5
, immune response
, lipopolysaccharide activated kinase
, mmune response deficient 5
, I-kappa-B kinase 2
, I-kappa-B-kinase beta
, nuclear factor NF-kappa-B inhibitor kinase beta
, inhibitor of kappaB kinase beta
, inhibitor of nuclear factor kappa B kinase beta subunit
, inhibitor of kappa light chain gene enhancer in B cells, kinase beta